MetaCap

Decoy Therapeutics (DCOY) vs Kairos Pharma (KAPA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Kairos Pharma is the larger company by market cap ($2.0 million vs $2.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DCOY-48.48%KAPA-49.90%
+14%-22%-57%
Oct 7, 20261 yearNov 20, 2026
DCOY-43.58%KAPA-46.21%
+2%-23%-49%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DCOY versus KAPA key metrics
MetricDCOYKAPA
Share price$0.8294$0.4359
Market cap$1.98M$2.04M
1-day change-4.68%-4.62%
P/E ratio (TTM)0.03—
EPS (TTM)$31.19$-2.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-12.52M$-5.45M
52-week high$16.92$7.28
52-week low$0.80$0.381
Distance from 52-week high-95.10%-94.01%
Analyst consensusstrong_buynone
Avg. price target upside+261.71%+11141.11%
Average volume2.17M364.25K
Shares outstanding2.39M4.69M
Employees111
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Decoy Therapeutics

DCOY stock →

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company.

Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees

About Kairos Pharma

KAPA stock →

Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.

Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees

DCOY vs KAPA FAQ

Which is bigger, Decoy Therapeutics or Kairos Pharma?

Kairos Pharma (KAPA) is larger, with a market capitalization of $2.04M compared with $1.98M for Decoy Therapeutics (DCOY).

Are Decoy Therapeutics and Kairos Pharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons